Our results revealed that BLCA samples with elevated FAM174B expression displayed reduced levels of the M1 macrophage marker CD86 and the DC marker CD11c, alongside increased staining of the M2 macrophage marker CD206 (Figure S7k). The gene discussed is CD86; the disease is bladder transitional cell carcinoma.